Global Legalized Cannabis
Global Legalized Cannabis

Legalized Cannabis Comprehensive Study by Type (Buds / Cannabis Flower, Cannabis Extracts), Application (Chronic Pain, Mental Disorders, Cancer, Others), Sales Channel (Online, Offline) Players and Region - Global Market Outlook to 2026

Legalized Cannabis Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Sep 2021 Edition 211 Pages 210 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Industry Background:
Legalized production of cannabis is that the production, sale, and possession of marijuana for recreational and medical usage. The broad legitimation of marijuana during this fashion will have various effects on the economy and society during which it's legalized. Legitimation provides governments the chance to control marijuana cultivation and sales by application, thereby making certain its contribution towards the country’s gross domestic product. Legitimation conjointly helps in moving cartels and contraband dealers out of business and reducing associated crime rates.This growth is primarily driven by Rising Government investment in Cannabis Research and Development and Increasing Demand for Cannabis in Medical Purpose and Recreational Purpose.

Globally, a noticeable market trend is evident Product Development and Research and Development in New Product Introduction for Legal purpose like Medical, Pharmaceutical. The Food Products sector in the North America region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Vendors, such as Canopy Growth Corporation (Canada), Aurora Cannabis (Canada), Aphria, Inc. (Canada), Tilray (Canada), ABcann Medicinals, Inc (Canada), The Cronos Group (Canada), Maricann Group, Inc. (Canada), Organigram Holding, Inc. (Canada) and Lexaria Corp. (Canada) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
In 2021, Curaleaf, the largest cannabis company, acquired European marijuana company Emmac Life Sciences. This acquisition will help Curaleaf strengthen its product portfolio of legal cannabis and fetch the expertise and wide consumer base with the highly spread network for distribution of cannabis.
In 2021, Canopy Growth Corporation, a world-leading diversified cannabis and vaporization device company, has entered the high-potential U.S. CBD beverage category with the launch of Quatreau, a premium ready-to-drink CBD-infused sparkling water. Quatreau sparkling water consists of 20 mg of premium, hemp-based CBD and four refreshing flavors.

Market Drivers
  • Rising Government investment in Cannabis Research and Development
  • Increasing Demand for Cannabis in Medical Purpose and Recreational Purpose

Market Trend
  • Product Development and Research and Development in New Product Introduction for Legal purpose like Medical, Pharmaceutical

Restraints
  • Stringent Government Regulations Regarding Cannabis in Different Countries

Opportunities
Rising Demand for the Legal Cannabis in Different Countries in Youth Population
Challenges
High Cost involved in Legal Cannabis and Availability of Substitutes in Market

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Vendors landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Legalized Cannabis Study Sheds Light on
— The Legalized Cannabis Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Legalized Cannabis industry Vendors. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Legalized Cannabis industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Vendors can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Frequently Asked Questions (FAQ):

1. What is the growth rate predicted for the Global Legalized Cannabis Market?
The Legalized Cannabis market is expected to see a CAGR of % during projected year 2020 to 2026.

2. Who are the top performing companies in Legalized Cannabis Market?
Top performing companies in the Global Legalized Cannabis market are Canopy Growth Corporation (Canada), Aurora Cannabis (Canada), Aphria, Inc. (Canada), Tilray (Canada), ABcann Medicinals, Inc (Canada), The Cronos Group (Canada), Maricann Group, Inc. (Canada), Organigram Holding, Inc. (Canada) and Lexaria Corp. (Canada), to name a few.

3. Which region dominated the worldwide market for Legalized Cannabis in 2020?
North America is dominating the Legalized Cannabis Market.
Report Objectives / Segmentation Covered
By Type
  • Buds / Cannabis Flower
  • Cannabis Extracts
By Application
  • Chronic Pain
  • Mental Disorders
  • Cancer
  • Others
By Sales Channel
  • Online
  • Offline

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Government investment in Cannabis Research and Development
      • 3.2.2. Increasing Demand for Cannabis in Medical Purpose and Recreational Purpose
    • 3.3. Market Challenges
      • 3.3.1. High Cost involved in Legal Cannabis and Availability of Substitutes in Market
    • 3.4. Market Trends
      • 3.4.1. Product Development and Research and Development in New Product Introduction for Legal purpose like Medical, Pharmaceutical
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Legalized Cannabis, by Type, Application, Sales Channel and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Legalized Cannabis (Value)
      • 5.2.1. Global Legalized Cannabis by: Type (Value)
        • 5.2.1.1. Buds / Cannabis Flower
        • 5.2.1.2. Cannabis Extracts
      • 5.2.2. Global Legalized Cannabis by: Application (Value)
        • 5.2.2.1. Chronic Pain
        • 5.2.2.2. Mental Disorders
        • 5.2.2.3. Cancer
        • 5.2.2.4. Others
      • 5.2.3. Global Legalized Cannabis by: Sales Channel (Value)
        • 5.2.3.1. Online
        • 5.2.3.2. Offline
      • 5.2.4. Global Legalized Cannabis Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Legalized Cannabis (Price)
      • 5.3.1. Global Legalized Cannabis by: Type (Price)
  • 6. Legalized Cannabis: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Canopy Growth Corporation (Canada)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Aurora Cannabis (Canada)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Aphria, Inc. (Canada)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Tilray (Canada)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. ABcann Medicinals, Inc (Canada)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. The Cronos Group (Canada)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Maricann Group, Inc. (Canada)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Organigram Holding, Inc. (Canada)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Lexaria Corp. (Canada)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Legalized Cannabis Sale, by Type, Application, Sales Channel and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Legalized Cannabis (Value)
      • 7.2.1. Global Legalized Cannabis by: Type (Value)
        • 7.2.1.1. Buds / Cannabis Flower
        • 7.2.1.2. Cannabis Extracts
      • 7.2.2. Global Legalized Cannabis by: Application (Value)
        • 7.2.2.1. Chronic Pain
        • 7.2.2.2. Mental Disorders
        • 7.2.2.3. Cancer
        • 7.2.2.4. Others
      • 7.2.3. Global Legalized Cannabis by: Sales Channel (Value)
        • 7.2.3.1. Online
        • 7.2.3.2. Offline
      • 7.2.4. Global Legalized Cannabis Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Legalized Cannabis (Price)
      • 7.3.1. Global Legalized Cannabis by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Legalized Cannabis: by Type(USD Million)
  • Table 2. Legalized Cannabis Buds / Cannabis Flower , by Region USD Million (2015-2020)
  • Table 3. Legalized Cannabis Cannabis Extracts , by Region USD Million (2015-2020)
  • Table 4. Legalized Cannabis: by Application(USD Million)
  • Table 5. Legalized Cannabis Chronic Pain , by Region USD Million (2015-2020)
  • Table 6. Legalized Cannabis Mental Disorders , by Region USD Million (2015-2020)
  • Table 7. Legalized Cannabis Cancer , by Region USD Million (2015-2020)
  • Table 8. Legalized Cannabis Others , by Region USD Million (2015-2020)
  • Table 9. Legalized Cannabis: by Sales Channel(USD Million)
  • Table 10. Legalized Cannabis Online , by Region USD Million (2015-2020)
  • Table 11. Legalized Cannabis Offline , by Region USD Million (2015-2020)
  • Table 12. South America Legalized Cannabis, by Country USD Million (2015-2020)
  • Table 13. South America Legalized Cannabis, by Type USD Million (2015-2020)
  • Table 14. South America Legalized Cannabis, by Application USD Million (2015-2020)
  • Table 15. South America Legalized Cannabis, by Sales Channel USD Million (2015-2020)
  • Table 16. Brazil Legalized Cannabis, by Type USD Million (2015-2020)
  • Table 17. Brazil Legalized Cannabis, by Application USD Million (2015-2020)
  • Table 18. Brazil Legalized Cannabis, by Sales Channel USD Million (2015-2020)
  • Table 19. Argentina Legalized Cannabis, by Type USD Million (2015-2020)
  • Table 20. Argentina Legalized Cannabis, by Application USD Million (2015-2020)
  • Table 21. Argentina Legalized Cannabis, by Sales Channel USD Million (2015-2020)
  • Table 22. Rest of South America Legalized Cannabis, by Type USD Million (2015-2020)
  • Table 23. Rest of South America Legalized Cannabis, by Application USD Million (2015-2020)
  • Table 24. Rest of South America Legalized Cannabis, by Sales Channel USD Million (2015-2020)
  • Table 25. Asia Pacific Legalized Cannabis, by Country USD Million (2015-2020)
  • Table 26. Asia Pacific Legalized Cannabis, by Type USD Million (2015-2020)
  • Table 27. Asia Pacific Legalized Cannabis, by Application USD Million (2015-2020)
  • Table 28. Asia Pacific Legalized Cannabis, by Sales Channel USD Million (2015-2020)
  • Table 29. China Legalized Cannabis, by Type USD Million (2015-2020)
  • Table 30. China Legalized Cannabis, by Application USD Million (2015-2020)
  • Table 31. China Legalized Cannabis, by Sales Channel USD Million (2015-2020)
  • Table 32. Japan Legalized Cannabis, by Type USD Million (2015-2020)
  • Table 33. Japan Legalized Cannabis, by Application USD Million (2015-2020)
  • Table 34. Japan Legalized Cannabis, by Sales Channel USD Million (2015-2020)
  • Table 35. India Legalized Cannabis, by Type USD Million (2015-2020)
  • Table 36. India Legalized Cannabis, by Application USD Million (2015-2020)
  • Table 37. India Legalized Cannabis, by Sales Channel USD Million (2015-2020)
  • Table 38. South Korea Legalized Cannabis, by Type USD Million (2015-2020)
  • Table 39. South Korea Legalized Cannabis, by Application USD Million (2015-2020)
  • Table 40. South Korea Legalized Cannabis, by Sales Channel USD Million (2015-2020)
  • Table 41. Taiwan Legalized Cannabis, by Type USD Million (2015-2020)
  • Table 42. Taiwan Legalized Cannabis, by Application USD Million (2015-2020)
  • Table 43. Taiwan Legalized Cannabis, by Sales Channel USD Million (2015-2020)
  • Table 44. Australia Legalized Cannabis, by Type USD Million (2015-2020)
  • Table 45. Australia Legalized Cannabis, by Application USD Million (2015-2020)
  • Table 46. Australia Legalized Cannabis, by Sales Channel USD Million (2015-2020)
  • Table 47. Rest of Asia-Pacific Legalized Cannabis, by Type USD Million (2015-2020)
  • Table 48. Rest of Asia-Pacific Legalized Cannabis, by Application USD Million (2015-2020)
  • Table 49. Rest of Asia-Pacific Legalized Cannabis, by Sales Channel USD Million (2015-2020)
  • Table 50. Europe Legalized Cannabis, by Country USD Million (2015-2020)
  • Table 51. Europe Legalized Cannabis, by Type USD Million (2015-2020)
  • Table 52. Europe Legalized Cannabis, by Application USD Million (2015-2020)
  • Table 53. Europe Legalized Cannabis, by Sales Channel USD Million (2015-2020)
  • Table 54. Germany Legalized Cannabis, by Type USD Million (2015-2020)
  • Table 55. Germany Legalized Cannabis, by Application USD Million (2015-2020)
  • Table 56. Germany Legalized Cannabis, by Sales Channel USD Million (2015-2020)
  • Table 57. France Legalized Cannabis, by Type USD Million (2015-2020)
  • Table 58. France Legalized Cannabis, by Application USD Million (2015-2020)
  • Table 59. France Legalized Cannabis, by Sales Channel USD Million (2015-2020)
  • Table 60. Italy Legalized Cannabis, by Type USD Million (2015-2020)
  • Table 61. Italy Legalized Cannabis, by Application USD Million (2015-2020)
  • Table 62. Italy Legalized Cannabis, by Sales Channel USD Million (2015-2020)
  • Table 63. United Kingdom Legalized Cannabis, by Type USD Million (2015-2020)
  • Table 64. United Kingdom Legalized Cannabis, by Application USD Million (2015-2020)
  • Table 65. United Kingdom Legalized Cannabis, by Sales Channel USD Million (2015-2020)
  • Table 66. Netherlands Legalized Cannabis, by Type USD Million (2015-2020)
  • Table 67. Netherlands Legalized Cannabis, by Application USD Million (2015-2020)
  • Table 68. Netherlands Legalized Cannabis, by Sales Channel USD Million (2015-2020)
  • Table 69. Rest of Europe Legalized Cannabis, by Type USD Million (2015-2020)
  • Table 70. Rest of Europe Legalized Cannabis, by Application USD Million (2015-2020)
  • Table 71. Rest of Europe Legalized Cannabis, by Sales Channel USD Million (2015-2020)
  • Table 72. MEA Legalized Cannabis, by Country USD Million (2015-2020)
  • Table 73. MEA Legalized Cannabis, by Type USD Million (2015-2020)
  • Table 74. MEA Legalized Cannabis, by Application USD Million (2015-2020)
  • Table 75. MEA Legalized Cannabis, by Sales Channel USD Million (2015-2020)
  • Table 76. Middle East Legalized Cannabis, by Type USD Million (2015-2020)
  • Table 77. Middle East Legalized Cannabis, by Application USD Million (2015-2020)
  • Table 78. Middle East Legalized Cannabis, by Sales Channel USD Million (2015-2020)
  • Table 79. Africa Legalized Cannabis, by Type USD Million (2015-2020)
  • Table 80. Africa Legalized Cannabis, by Application USD Million (2015-2020)
  • Table 81. Africa Legalized Cannabis, by Sales Channel USD Million (2015-2020)
  • Table 82. North America Legalized Cannabis, by Country USD Million (2015-2020)
  • Table 83. North America Legalized Cannabis, by Type USD Million (2015-2020)
  • Table 84. North America Legalized Cannabis, by Application USD Million (2015-2020)
  • Table 85. North America Legalized Cannabis, by Sales Channel USD Million (2015-2020)
  • Table 86. United States Legalized Cannabis, by Type USD Million (2015-2020)
  • Table 87. United States Legalized Cannabis, by Application USD Million (2015-2020)
  • Table 88. United States Legalized Cannabis, by Sales Channel USD Million (2015-2020)
  • Table 89. Canada Legalized Cannabis, by Type USD Million (2015-2020)
  • Table 90. Canada Legalized Cannabis, by Application USD Million (2015-2020)
  • Table 91. Canada Legalized Cannabis, by Sales Channel USD Million (2015-2020)
  • Table 92. Mexico Legalized Cannabis, by Type USD Million (2015-2020)
  • Table 93. Mexico Legalized Cannabis, by Application USD Million (2015-2020)
  • Table 94. Mexico Legalized Cannabis, by Sales Channel USD Million (2015-2020)
  • Table 95. Legalized Cannabis: by Type(USD/Units)
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Legalized Cannabis: by Type(USD Million)
  • Table 106. Legalized Cannabis Buds / Cannabis Flower , by Region USD Million (2021-2026)
  • Table 107. Legalized Cannabis Cannabis Extracts , by Region USD Million (2021-2026)
  • Table 108. Legalized Cannabis: by Application(USD Million)
  • Table 109. Legalized Cannabis Chronic Pain , by Region USD Million (2021-2026)
  • Table 110. Legalized Cannabis Mental Disorders , by Region USD Million (2021-2026)
  • Table 111. Legalized Cannabis Cancer , by Region USD Million (2021-2026)
  • Table 112. Legalized Cannabis Others , by Region USD Million (2021-2026)
  • Table 113. Legalized Cannabis: by Sales Channel(USD Million)
  • Table 114. Legalized Cannabis Online , by Region USD Million (2021-2026)
  • Table 115. Legalized Cannabis Offline , by Region USD Million (2021-2026)
  • Table 116. South America Legalized Cannabis, by Country USD Million (2021-2026)
  • Table 117. South America Legalized Cannabis, by Type USD Million (2021-2026)
  • Table 118. South America Legalized Cannabis, by Application USD Million (2021-2026)
  • Table 119. South America Legalized Cannabis, by Sales Channel USD Million (2021-2026)
  • Table 120. Brazil Legalized Cannabis, by Type USD Million (2021-2026)
  • Table 121. Brazil Legalized Cannabis, by Application USD Million (2021-2026)
  • Table 122. Brazil Legalized Cannabis, by Sales Channel USD Million (2021-2026)
  • Table 123. Argentina Legalized Cannabis, by Type USD Million (2021-2026)
  • Table 124. Argentina Legalized Cannabis, by Application USD Million (2021-2026)
  • Table 125. Argentina Legalized Cannabis, by Sales Channel USD Million (2021-2026)
  • Table 126. Rest of South America Legalized Cannabis, by Type USD Million (2021-2026)
  • Table 127. Rest of South America Legalized Cannabis, by Application USD Million (2021-2026)
  • Table 128. Rest of South America Legalized Cannabis, by Sales Channel USD Million (2021-2026)
  • Table 129. Asia Pacific Legalized Cannabis, by Country USD Million (2021-2026)
  • Table 130. Asia Pacific Legalized Cannabis, by Type USD Million (2021-2026)
  • Table 131. Asia Pacific Legalized Cannabis, by Application USD Million (2021-2026)
  • Table 132. Asia Pacific Legalized Cannabis, by Sales Channel USD Million (2021-2026)
  • Table 133. China Legalized Cannabis, by Type USD Million (2021-2026)
  • Table 134. China Legalized Cannabis, by Application USD Million (2021-2026)
  • Table 135. China Legalized Cannabis, by Sales Channel USD Million (2021-2026)
  • Table 136. Japan Legalized Cannabis, by Type USD Million (2021-2026)
  • Table 137. Japan Legalized Cannabis, by Application USD Million (2021-2026)
  • Table 138. Japan Legalized Cannabis, by Sales Channel USD Million (2021-2026)
  • Table 139. India Legalized Cannabis, by Type USD Million (2021-2026)
  • Table 140. India Legalized Cannabis, by Application USD Million (2021-2026)
  • Table 141. India Legalized Cannabis, by Sales Channel USD Million (2021-2026)
  • Table 142. South Korea Legalized Cannabis, by Type USD Million (2021-2026)
  • Table 143. South Korea Legalized Cannabis, by Application USD Million (2021-2026)
  • Table 144. South Korea Legalized Cannabis, by Sales Channel USD Million (2021-2026)
  • Table 145. Taiwan Legalized Cannabis, by Type USD Million (2021-2026)
  • Table 146. Taiwan Legalized Cannabis, by Application USD Million (2021-2026)
  • Table 147. Taiwan Legalized Cannabis, by Sales Channel USD Million (2021-2026)
  • Table 148. Australia Legalized Cannabis, by Type USD Million (2021-2026)
  • Table 149. Australia Legalized Cannabis, by Application USD Million (2021-2026)
  • Table 150. Australia Legalized Cannabis, by Sales Channel USD Million (2021-2026)
  • Table 151. Rest of Asia-Pacific Legalized Cannabis, by Type USD Million (2021-2026)
  • Table 152. Rest of Asia-Pacific Legalized Cannabis, by Application USD Million (2021-2026)
  • Table 153. Rest of Asia-Pacific Legalized Cannabis, by Sales Channel USD Million (2021-2026)
  • Table 154. Europe Legalized Cannabis, by Country USD Million (2021-2026)
  • Table 155. Europe Legalized Cannabis, by Type USD Million (2021-2026)
  • Table 156. Europe Legalized Cannabis, by Application USD Million (2021-2026)
  • Table 157. Europe Legalized Cannabis, by Sales Channel USD Million (2021-2026)
  • Table 158. Germany Legalized Cannabis, by Type USD Million (2021-2026)
  • Table 159. Germany Legalized Cannabis, by Application USD Million (2021-2026)
  • Table 160. Germany Legalized Cannabis, by Sales Channel USD Million (2021-2026)
  • Table 161. France Legalized Cannabis, by Type USD Million (2021-2026)
  • Table 162. France Legalized Cannabis, by Application USD Million (2021-2026)
  • Table 163. France Legalized Cannabis, by Sales Channel USD Million (2021-2026)
  • Table 164. Italy Legalized Cannabis, by Type USD Million (2021-2026)
  • Table 165. Italy Legalized Cannabis, by Application USD Million (2021-2026)
  • Table 166. Italy Legalized Cannabis, by Sales Channel USD Million (2021-2026)
  • Table 167. United Kingdom Legalized Cannabis, by Type USD Million (2021-2026)
  • Table 168. United Kingdom Legalized Cannabis, by Application USD Million (2021-2026)
  • Table 169. United Kingdom Legalized Cannabis, by Sales Channel USD Million (2021-2026)
  • Table 170. Netherlands Legalized Cannabis, by Type USD Million (2021-2026)
  • Table 171. Netherlands Legalized Cannabis, by Application USD Million (2021-2026)
  • Table 172. Netherlands Legalized Cannabis, by Sales Channel USD Million (2021-2026)
  • Table 173. Rest of Europe Legalized Cannabis, by Type USD Million (2021-2026)
  • Table 174. Rest of Europe Legalized Cannabis, by Application USD Million (2021-2026)
  • Table 175. Rest of Europe Legalized Cannabis, by Sales Channel USD Million (2021-2026)
  • Table 176. MEA Legalized Cannabis, by Country USD Million (2021-2026)
  • Table 177. MEA Legalized Cannabis, by Type USD Million (2021-2026)
  • Table 178. MEA Legalized Cannabis, by Application USD Million (2021-2026)
  • Table 179. MEA Legalized Cannabis, by Sales Channel USD Million (2021-2026)
  • Table 180. Middle East Legalized Cannabis, by Type USD Million (2021-2026)
  • Table 181. Middle East Legalized Cannabis, by Application USD Million (2021-2026)
  • Table 182. Middle East Legalized Cannabis, by Sales Channel USD Million (2021-2026)
  • Table 183. Africa Legalized Cannabis, by Type USD Million (2021-2026)
  • Table 184. Africa Legalized Cannabis, by Application USD Million (2021-2026)
  • Table 185. Africa Legalized Cannabis, by Sales Channel USD Million (2021-2026)
  • Table 186. North America Legalized Cannabis, by Country USD Million (2021-2026)
  • Table 187. North America Legalized Cannabis, by Type USD Million (2021-2026)
  • Table 188. North America Legalized Cannabis, by Application USD Million (2021-2026)
  • Table 189. North America Legalized Cannabis, by Sales Channel USD Million (2021-2026)
  • Table 190. United States Legalized Cannabis, by Type USD Million (2021-2026)
  • Table 191. United States Legalized Cannabis, by Application USD Million (2021-2026)
  • Table 192. United States Legalized Cannabis, by Sales Channel USD Million (2021-2026)
  • Table 193. Canada Legalized Cannabis, by Type USD Million (2021-2026)
  • Table 194. Canada Legalized Cannabis, by Application USD Million (2021-2026)
  • Table 195. Canada Legalized Cannabis, by Sales Channel USD Million (2021-2026)
  • Table 196. Mexico Legalized Cannabis, by Type USD Million (2021-2026)
  • Table 197. Mexico Legalized Cannabis, by Application USD Million (2021-2026)
  • Table 198. Mexico Legalized Cannabis, by Sales Channel USD Million (2021-2026)
  • Table 199. Legalized Cannabis: by Type(USD/Units)
  • Table 200. Research Programs/Design for This Report
  • Table 201. Key Data Information from Secondary Sources
  • Table 202. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Legalized Cannabis: by Type USD Million (2015-2020)
  • Figure 5. Global Legalized Cannabis: by Application USD Million (2015-2020)
  • Figure 6. Global Legalized Cannabis: by Sales Channel USD Million (2015-2020)
  • Figure 7. South America Legalized Cannabis Share (%), by Country
  • Figure 8. Asia Pacific Legalized Cannabis Share (%), by Country
  • Figure 9. Europe Legalized Cannabis Share (%), by Country
  • Figure 10. MEA Legalized Cannabis Share (%), by Country
  • Figure 11. North America Legalized Cannabis Share (%), by Country
  • Figure 12. Global Legalized Cannabis: by Type USD/Units (2015-2020)
  • Figure 13. Global Legalized Cannabis share by Players 2020 (%)
  • Figure 14. Global Legalized Cannabis share by Players (Top 3) 2020(%)
  • Figure 15. Global Legalized Cannabis share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Canopy Growth Corporation (Canada) Revenue, Net Income and Gross profit
  • Figure 18. Canopy Growth Corporation (Canada) Revenue: by Geography 2020
  • Figure 19. Aurora Cannabis (Canada) Revenue, Net Income and Gross profit
  • Figure 20. Aurora Cannabis (Canada) Revenue: by Geography 2020
  • Figure 21. Aphria, Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 22. Aphria, Inc. (Canada) Revenue: by Geography 2020
  • Figure 23. Tilray (Canada) Revenue, Net Income and Gross profit
  • Figure 24. Tilray (Canada) Revenue: by Geography 2020
  • Figure 25. ABcann Medicinals, Inc (Canada) Revenue, Net Income and Gross profit
  • Figure 26. ABcann Medicinals, Inc (Canada) Revenue: by Geography 2020
  • Figure 27. The Cronos Group (Canada) Revenue, Net Income and Gross profit
  • Figure 28. The Cronos Group (Canada) Revenue: by Geography 2020
  • Figure 29. Maricann Group, Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 30. Maricann Group, Inc. (Canada) Revenue: by Geography 2020
  • Figure 31. Organigram Holding, Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 32. Organigram Holding, Inc. (Canada) Revenue: by Geography 2020
  • Figure 33. Lexaria Corp. (Canada) Revenue, Net Income and Gross profit
  • Figure 34. Lexaria Corp. (Canada) Revenue: by Geography 2020
  • Figure 35. Global Legalized Cannabis: by Type USD Million (2021-2026)
  • Figure 36. Global Legalized Cannabis: by Application USD Million (2021-2026)
  • Figure 37. Global Legalized Cannabis: by Sales Channel USD Million (2021-2026)
  • Figure 38. South America Legalized Cannabis Share (%), by Country
  • Figure 39. Asia Pacific Legalized Cannabis Share (%), by Country
  • Figure 40. Europe Legalized Cannabis Share (%), by Country
  • Figure 41. MEA Legalized Cannabis Share (%), by Country
  • Figure 42. North America Legalized Cannabis Share (%), by Country
  • Figure 43. Global Legalized Cannabis: by Type USD/Units (2021-2026)
Some of the key companies/manufacturers profiled in the report
  • Canopy Growth Corporation (Canada)
  • Aurora Cannabis (Canada)
  • Aphria, Inc. (Canada)
  • Tilray (Canada)
  • ABcann Medicinals, Inc (Canada)
  • The Cronos Group (Canada)
  • Maricann Group, Inc. (Canada)
  • Organigram Holding, Inc. (Canada)
  • Lexaria Corp. (Canada)
Additional players considered in the study are as follows:
Curaleaf (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation